Acquisitions - Restore Endosystems, LLC (Details) - Restore Endosystems $ in Millions |
Apr. 30, 2022
USD ($)
|
---|---|
Asset Acquisition [Line Items] | |
Cash paid at closing | $ 3.0 |
Additional payments upon the achievement of specified milestones | 3.5 |
In-process research and development | |
Asset Acquisition [Line Items] | |
Acquired intangible assets | 6.5 |
First Payment | |
Asset Acquisition [Line Items] | |
Additional payments upon the achievement of specified milestones | $ 2.0 |
Payment period | 2 years |
Second Payment | |
Asset Acquisition [Line Items] | |
Additional payments upon the achievement of specified milestones | $ 2.0 |
Payment period | 4 years |
X | ||||||||||
- Definition Represents the period for which an asset acquisition contingent consideration is to be paid. No definition available.
|
X | ||||||||||
- Definition Amount of contingent consideration recognized as part of consideration transferred in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|